Cargando…
Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study
BACKGROUND: Graft-derived cell-free DNA (GcfDNA), which is released into the blood stream by necrotic and apoptotic cells, is a promising noninvasive organ integrity biomarker. In liver transplantation (LTx), neither conventional liver function tests (LTFs) nor immunosuppressive drug monitoring are...
Autores principales: | Schütz, Ekkehard, Fischer, Anna, Beck, Julia, Harden, Markus, Koch, Martina, Wuensch, Tilo, Stockmann, Martin, Nashan, Björn, Kollmar, Otto, Matthaei, Johannes, Kanzow, Philipp, Walson, Philip D., Brockmöller, Jürgen, Oellerich, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404754/ https://www.ncbi.nlm.nih.gov/pubmed/28441386 http://dx.doi.org/10.1371/journal.pmed.1002286 |
Ejemplares similares
-
Absolute quantification of donor‐derived cell‐free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study
por: Oellerich, Michael, et al.
Publicado: (2019) -
Donor-derived cell-free DNA as a diagnostic tool in transplantation
por: Oellerich, Michael, et al.
Publicado: (2022) -
Graft rejection in component keratoplasty
por: Deshmukh, Rashmi, et al.
Publicado: (2023) -
Immunopathogenesis of corneal graft rejection
por: Maharana, Prafulla Kumar, et al.
Publicado: (2023) -
Machine Learning Analysis of Postkeratoplasty Endothelial Cell Images for the Prediction of Future Graft Rejection
por: Joseph, Naomi, et al.
Publicado: (2023)